Concord Medical Services Holdings Limited (NYSE:CCM) Short Interest Update

Concord Medical Services Holdings Limited (NYSE:CCM) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totaling 7,483 shares, a growth of 134.9% from the April 30th total of 3,186 shares. Based on an average trading volume of 86,277 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.3% of the shares of the stock are short sold.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Concord Medical Services in a research report on Tuesday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Concord Medical Services Stock Performance

Shares of NYSE:CCM traded up $0.08 during midday trading on Friday, reaching $4.98. The company’s stock had a trading volume of 7,813 shares, compared to its average volume of 62,582. Concord Medical Services has a 1 year low of $3.18 and a 1 year high of $10.77. The business has a 50 day moving average price of $4.27 and a 200 day moving average price of $4.13. The company has a debt-to-equity ratio of 1.33, a current ratio of 0.48 and a quick ratio of 0.46.

Concord Medical Services (NYSE:CCM) last posted its quarterly earnings data on Wednesday, April 29th. The company reported ($1.08) EPS for the quarter.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.